Vanguard Capital Wealth Advisors

Position in JNJ — Johnson & Johnson

CIK 1730578 DENVER, CO

Position in JNJ

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$302,478

+$2,306 QoQ

Shares Held

1,191

-3.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#4,172

of 4,676 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Vanguard Capital Wealth Advisors holds $3,241,473 across 6 Drug Manufacturers - General names. JNJ ranks #5 (9.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	3,858	$970,827
2	LLY	ELI LILLY & Co	735	$881,581
3	BMY	Bristol Myers Squibb Co	9,127	$525,897
4	NVS	Novartis AG	2,050	$321,276
5	JNJ	Johnson & Johnson This page	1,191	$302,478
6	GILD	Gilead Sciences, Inc.	1,895	$239,414

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$302,478	1,191	-3.0%	Shares	Sole	2026-07-23
2026-03-31	$300,172	1,228	-2.1%	Shares	Sole	2026-04-21
2025-12-31	$259,515	1,254	+1.7%	Shares	Sole	2026-01-16
2025-09-30	$228,622	1,233	-0.3%	Shares	Sole	2025-10-30
2024-09-30	$200,468	1,237	-12.9%	Shares	Sole	2024-10-25
2024-03-31	$224,629	1,420	-0.3%	Shares	Sole	2024-04-16
2023-12-31	$223,197	1,424	0.0%	Shares	Sole	2024-02-05
2023-09-30	$221,788	1,424	-11.2%	Shares	Sole	2023-11-01
2021-12-31	$274,225	1,603	0.0%	Shares	Sole	2022-02-02
2021-09-30	$258,884	1,603	-1.5%	Shares	Sole	2021-11-01
2021-06-30	$268,031	1,627	-5.7%	Shares	Sole	2021-07-28
2021-03-31	$283,668	1,726	+13.1%	Shares	Sole	2021-04-12
2020-12-31	$240,161	1,526	-22.7%	Shares	Sole	2021-01-25
2020-06-30	$277,462	1,973	—	Shares	Sole	2020-08-05
No filing history on record for this holder in this stock.